Investigating the reasons for low and delayed screening of primary Aldosteronism
Understanding and addressing the lack of and delayed screening for primary Aldosteronism
This study is looking into why not enough people at risk for primary aldosteronism get tested for it, even though it can cause serious health problems, and it aims to find ways to make screening easier and more accessible for everyone.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Mayo Clinic Rochester NIH-funded |
| Lab location | 1 site (Rochester, United States) |
| Project ID | NIH-11048613 on NIH RePORTER |
What this research studies
This research aims to understand why so few individuals at risk for primary aldosteronism (PA) are screened for this condition, which can lead to serious health issues like cardiovascular and renal complications. By examining various factors such as patient demographics, clinician practices, and healthcare system barriers, the study seeks to identify the root causes of inadequate screening. The project will utilize linked datasets, including insurance claims and electronic health records, to analyze current screening patterns and disparities. Ultimately, the goal is to develop interventions that improve the accessibility and timeliness of PA screening for all patients.
Who could benefit from this research
Good fit: Ideal candidates for this research include adults who are at risk for primary aldosteronism, particularly those with hypertension or related cardiovascular conditions.
Not a fit: Patients who do not have hypertension or related risk factors for primary aldosteronism may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved screening rates for primary aldosteronism, resulting in better health outcomes and reduced complications for patients.
How similar studies have performed: Previous research has shown that addressing barriers to screening can improve health outcomes, suggesting that this approach may yield significant benefits.
Where this research is happening
Rochester, United States
- Mayo Clinic Rochester — Rochester, United States (Active)
Researchers
- Principal investigator: Brito Campana, Juan P — Mayo Clinic Rochester
- Study coordinator: Brito Campana, Juan P
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.